Veozah — CareFirst (Caremark)

Initial criteria

• The requested drug is being prescribed for the treatment of moderate to severe vasomotor symptoms due to menopause.

Reauthorization criteria

• The requested drug is being prescribed for the treatment of moderate to severe vasomotor symptoms due to menopause.
• The patient has achieved or maintained a positive clinical response to the requested drug.
• The patient has been re-evaluated periodically to determine if treatment is still medically necessary.

Approval duration

12 months